Medical Device Deals Update, September 2014
Executive Summary
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Medical Device Deals Update column is a survey of recent medtech M&A, alliance, and financing activity. This month’s column covers deals announced in late July-September 2014.
You may also be interested in...
Device Debuts: Medtronic, Boston Scientific, Philips, Seventh Sense, Vortex, 410 Medical
Device Debuts is a new regular feature highlighting Medtech Insight editors’ top picks of medical devices that have been commercialized for the first time in the last month. This edition features an innovative minimally invasive surgical stapler, a pain-free blood-collection device, a novel approach for collecting, and circulating tumor cells, a rapid fluid-infusion device for critically ill patients, and an EP-mapping and navigation system.
US FDA Announces Update To Recognized Standards List
The national and international standards can be used during the device assessment process.
Neurocrine Closer To Ingrezza Label Expansion With Huntington’s Chorea Phase III Win
The neuroscience-focused firm plans a 2022 supplemental NDA for Ingrezza following success in the pivotal KINECT-HD study. The biotech needed an R&D success after recent stumbles.